Director, CEO and President, 10% Owner · Tempest Therapeutics, Inc. · Common Stock
Side
BUY
Value
$500K
Shares
231.5K
Price
$2.16
Executed
Mar 24, 2026
Disclosed
Mar 25, 2026
Disclosure timeline1 days from execution to publication · legal deadline 2 business days
Mar 24 executedMar 25, 2026 disclosed
TPST · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Disclosed 1 business day after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Angel Matthew filed this Form 4 reporting a open-market purchase of TPST on Mar 24, 2026. It became public on Mar 25, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Director, CEO and President, 10% Owner
Angel Matthewcik:0001931356
Issuer
Tempest Therapeutics, Inc.cik:0001544227
Revision history · 0
No field has changed since this record was first ingested.
